1I
1stdibs.com, Inc. (DIBS)·Q3 2025 Earnings Summary
Executive Summary
- 1stDibs delivered a cleaner, margin-focused Q3: net revenue $22.0M (+4% y/y), gross margin 74.3% (+330 bps y/y), and Adjusted EBITDA margin improved to (1.1)%, the best since listing, driven by cost realignment and tighter performance marketing .
- Results modestly beat consensus: revenue $22.0M vs $21.5M consensus and EPS ($0.10) vs ($0.13) consensus; Street now needs to reflect a faster path to profitability as management guides to positive Adjusted EBITDA in Q4 and FY26* .
- Q4 outlook implies sustained discipline: GMV $90–96M, revenue $22.3–23.5M, and Adjusted EBITDA margin +2% to +5% (vs negative in Q3), aided by subscription pricing actions effective Oct 1 and lower paid traffic spend .
- A $12M share repurchase authorization underscores confidence and adds near‑term support while the company leans into product/AI and price parity enforcement to drive conversion and trust .
What Went Well and What Went Wrong
-
What Went Well
- Structural margin step-up: Adjusted EBITDA margin improved to (1.1)% from (14.1)% y/y; operating expenses were down 6% y/y (down ~10% ex-severance) as 1stDibs reallocated spend from sales/marketing to product/engineering .
- Conversion and AOV improvements: 8th consecutive quarter of conversion growth; on-platform AOV (
$2,700) and median order value ($1,300) both up ~10% y/y; GMV accelerated to +5% y/y from (2)% in Q2 . - Trust and pricing innovations: ML-based pricing across verticals and price parity enforcement (90% violations remedied) lifted conversion on updated items; ~25% of new code now written by AI to accelerate product velocity .
-
What Went Wrong
- Traffic softness: Paid traffic reduced by stricter efficiency thresholds; >75% traffic now organic (+3ppt y/y), but lower paid traffic is a near‑term headwind to order volume .
- Take rate compression: Take rate declined ~40 bps y/y on mix shift toward higher value orders, partially offsetting GMV gains .
- One-time boost to gross margin: Reported GM of 74% included ~100 bps non-recurring insurance recovery; adjusted gross margins were at the high end of the 71–73% range .
Financial Results
Vs consensus (Q3 2025):
- Revenue: Actual $21.972M vs $21.509M consensus (beat)* .
- EPS: Actual ($0.10) vs ($0.13) consensus (beat)* .
Values retrieved from S&P Global.*
KPIs and Marketplace Health
Selected Mix/Other
- Transaction revenue ~75% of total; subscriptions most of the remainder .
- Take rate down ~40 bps y/y on mix shift to higher-value orders .
Guidance Changes
Notes:
- Management expects positive Adjusted EBITDA in Q4 and for FY2026 .
- No explicit guidance given for OpEx, OI&E, tax, or dividends.
Earnings Call Themes & Trends
Management Commentary
- “We successfully completed a major strategic realignment…our best Adjusted EBITDA margin as a public company…well positioned for profitability and market share gains even in a challenging environment.” – CEO David Rosenblatt .
- “Adjusted EBITDA well above guidance…on track to achieve positive Adjusted EBITDA in the fourth quarter and for the full-year 2026…Board authorized a $12 million share repurchase program.” – CFO Tom Etergino .
- “We launched…automated enforcement…ensures items…are priced at or below their price on competing sites…nearly 90% of identified violations have been remedied by sellers.” – CEO .
- “Operating expenses were down 6% year over year and down 10% when excluding severance costs…Sales and marketing…36% of revenue, down from 44% a year ago.” – CFO .
- “Within engineering, we estimate that over 25% of all new code is being written by AI, accelerating our development process.” – CEO .
Q&A Highlights
- Strategic realignment rationale: Multi-year effort reduced GMV breakeven by almost $250M; reallocated headcount from sales/marketing to product/engineering; goal is sustained profitability and positive FCF for FY26 .
- Seller pricing changes: Oct 1 targeted subscription increase (~10% on ~20% of sellers) and certain commission increases; no meaningful increase in churn observed .
- Guidance tone: Accepting lower traffic and orders in exchange for higher margins/unit economics; Q4 revenue aided by full-quarter subscription pricing benefit .
Estimates Context
- Q3 2025 actuals vs consensus: revenue $21.972M vs $21.509M (beat), EPS ($0.10) vs ($0.13) (beat)* .
- Q4 2025 set-up: guidance revenue $22.3–$23.5M vs Street $22.866M*; EPS Street ($0.05); management guiding to positive Adjusted EBITDA margin (+2% to +5%), indicating a profitability inflection ahead of prior expectations .
Values retrieved from S&P Global.
Key Takeaways for Investors
- Profitability pivot underway: Structural cost reset and marketing discipline delivered the best public-company Adjusted EBITDA margin; Q4 guide implies turning positive .
- Near-term revenue quality over volume: Reduced paid traffic and tighter thresholds will likely suppress order growth but improve unit economics and margins .
- Trust and monetization levers: Price parity enforcement and ML pricing are lifting conversion; subscription pricing/commission changes add recurring revenue tailwinds without incremental churn to date .
- Mix matters: Take rate compressed ~40 bps y/y on higher-value order mix; watch mix shifts and any impact from macro-sensitive high-ticket categories .
- Capital return supports shares: New $12M buyback provides downside support as free cash flow inflects over the next 4–6 quarters .
- Watch Q4 execution: Gross margin at high end of the 71–73% range and positive EBITDA will be key print metrics; note Q3 benefited ~100 bps from an insurance recovery .
- Medium-term thesis: Product/AI velocity and marketplace trust can drive share gains in a soft macro, with an asset-light model enabling margin expansion as growth resumes .
Appendix: Additional Items
- Balance sheet: Cash, cash equivalents and short‑term investments totaled $93.4M as of 9/30/25 .
- Share repurchase: $12M authorization on 11/4/25, replacing prior program; timing/volume at company discretion .
- Definitions and reconciliations: Non‑GAAP Adjusted EBITDA reconciliations provided in press release and 8‑K exhibits .
S&P Global estimates disclaimer: All figures marked with an asterisk (*) are values retrieved from S&P Global.